T. Kiran Et Al. , "The significance of MUM1/IRF4 protein expression and IRF4 translocation of CD30(+) cutaneous T-cell lymphoproliferative disorders: A study of 53 cases," LEUKEMIA RESEARCH , vol.37, no.4, pp.396-400, 2013
Kiran, T. Et Al. 2013. The significance of MUM1/IRF4 protein expression and IRF4 translocation of CD30(+) cutaneous T-cell lymphoproliferative disorders: A study of 53 cases. LEUKEMIA RESEARCH , vol.37, no.4 , 396-400.
Kiran, T., Demirkesen, C., Eker, C., Kumusoglu, H., & Tuzuner, N., (2013). The significance of MUM1/IRF4 protein expression and IRF4 translocation of CD30(+) cutaneous T-cell lymphoproliferative disorders: A study of 53 cases. LEUKEMIA RESEARCH , vol.37, no.4, 396-400.
Kiran, Tugce Et Al. "The significance of MUM1/IRF4 protein expression and IRF4 translocation of CD30(+) cutaneous T-cell lymphoproliferative disorders: A study of 53 cases," LEUKEMIA RESEARCH , vol.37, no.4, 396-400, 2013
Kiran, Tugce Et Al. "The significance of MUM1/IRF4 protein expression and IRF4 translocation of CD30(+) cutaneous T-cell lymphoproliferative disorders: A study of 53 cases." LEUKEMIA RESEARCH , vol.37, no.4, pp.396-400, 2013
Kiran, T. Et Al. (2013) . "The significance of MUM1/IRF4 protein expression and IRF4 translocation of CD30(+) cutaneous T-cell lymphoproliferative disorders: A study of 53 cases." LEUKEMIA RESEARCH , vol.37, no.4, pp.396-400.
@article{article, author={Tugce Kiran Et Al. }, title={The significance of MUM1/IRF4 protein expression and IRF4 translocation of CD30(+) cutaneous T-cell lymphoproliferative disorders: A study of 53 cases}, journal={LEUKEMIA RESEARCH}, year=2013, pages={396-400} }